Brief

The New Drugs and Clinical Trials Rules, 2019 aim to standardize drug approvals and clinical trials in India, emphasizing safety, transparency, and efficiency. Key provisions include mandatory ethics committee approval, fast-track approval for critical drugs, and clear guidelines for participant compensation. The Rules enhance India’s role in global clinical research.

This content is restricted.

Highlights content goes here...

This content is restricted.

Central Drugs Standard Control Organization

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies